Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Cardiovascular Drug Reviews|September 12, 2006
CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channelsDe-Zai DaiCardiovascular Drug Reviews|September 12, 2006
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersPaolo Gresele, Stefania MomiCardiovascular Drug Reviews|January 12, 2007
Therapeutic use of citrulline in cardiovascular diseaseMaritza J Romero, Daniel H Platt, Ruth B Caldwell, et al.Cardiovascular Drug Reviews|July 12, 2005
Pharmacological actions of sodium ferulate in cardiovascular systemBao-Hua Wang, Jing-Ping Ou-YangCardiovascular Drug Reviews|April 21, 2007
Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trialsToshiki Miyazaki, Hiroyuki Fujiki, Yoshitaka Yamamura, et al.Cardiovascular Drug Reviews|April 21, 2007
N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blockerChristian Harteneck, Henning Frenzel, Robert KraftCardiovascular Drug Reviews|October 9, 2007
F90927: a new member in the class of cardioactive steroidsMarkus Keller, Christophe Pignier, Marcel Egger, et al.Cardiovascular Drug Reviews|October 9, 2007
Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitorsPál Pacher, Csaba SzabóCardiovascular Drug Reviews|October 28, 2005
Disodium disuccinate astaxanthin (Cardax): antioxidant and antiinflammatory cardioprotectionSamuel F Lockwood, Garrett J GrossCardiovascular Drug Reviews|February 22, 2003
Enrasentan, an antagonist of endothelin receptorsAlessandro CosenziPageof 16